1 completed, 1 not yet recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow PG-102(MG12): new trials by email Literature Review of PG-102(MG12) trials Research Report on PG-102(MG12)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II Study of Switching From Dulaglutide to PG-102(MG12) in Type 2 Diabetes Mellitus PG-102(MG12), Dulaglutide - Type 2 Diabetes | Phase 2 | Not yet recruiting | ProGen. Co., Ltd. | 60 | 2026-10-01 | 2026-07-01 |
| A Study to Investigate the Safety, Tolerability, and Pharmacokinetics and Pharmacodynamics Following Subcutaneous Injections of PG-102 (MG12) in Healthy Adult and Obesity Participants. PG-102(MG12), Placebo - Healthy, Overweight | Phase 1 | Completed | ProGen. Co., Ltd. | 102 | 2024-03-04 | 2025-05-06 |
Diabetes Mellitus, Type 2 (1) · Overweight (1)
South Korea (1)